{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:08:55Z","timestamp":1791396535839,"version":"4.3.3"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.kint.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T18:31:21Z","timestamp":1477593081000},"page":"412-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Ellian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yow","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yih","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Kuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsian-Jean","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kuang","family":"Leo Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Shiuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ying","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Tse","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sou-Tyau","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu Mei","family":"Hsieh-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.09.005_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2016.09.005_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A\u00a0critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2016.09.005_bib4","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.09.005_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","article-title":"Polycystin-1: a master regulator of intersecting cystic pathways","volume":"20","author":"Fedeles","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2016.09.005_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation","volume":"17","author":"Lu","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2016.09.005_bib7","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ng0803-355","article-title":"From cilia to cyst","volume":"34","author":"Watnick","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2016.09.005_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1681\/ASN.2011030284","article-title":"Third-hit signaling in renal cyst formation","volume":"22","author":"Weimbs","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib10","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.09.005_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A\u00a0polycystin-centric view of cyst formation and disease: the polycystins revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","article-title":"Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1","volume":"168","author":"Jiang","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.09.005_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.2765","article-title":"Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1","volume":"222","author":"Wang","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2016.09.005_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.111","article-title":"A\u00a0mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1","volume":"73","author":"Starremans","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib15","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1681\/ASN.2007101139","article-title":"Pkd1 inactivation induced in adulthood produces focal cystic disease","volume":"19","author":"Takakura","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1097-2765(02)00710-4","article-title":"An iron delivery pathway mediated by a lipocalin","volume":"10","author":"Yang","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.kint.2016.09.005_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.kint.2016.09.005_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1073\/pnas.0510847103","article-title":"Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury","volume":"103","author":"Berger","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.09.005_bib19","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2016.09.005_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/eci.12283","article-title":"Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI","volume":"44","author":"Urbschat","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2016.09.005_bib22","first-page":"197","article-title":"Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department","volume":"13","author":"Di Grande","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.kint.2016.09.005_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/bmm.13.149","article-title":"NGAL for the detection of acute kidney injury in the emergency room","volume":"8","author":"Devarajan","year":"2014","journal-title":"Biomark Med"},{"key":"10.1016\/j.kint.2016.09.005_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.2012.195","article-title":"NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease","volume":"82","author":"Nickolas","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/nep.12203","article-title":"Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease","volume":"19","author":"Shen","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2016.09.005_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ki.2011.465","article-title":"Evaluation of urine biomarkers of kidney injury in polycystic kidney disease","volume":"81","author":"Parikh","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","article-title":"Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis","volume":"56","author":"Meijer","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.09.005_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI23056","article-title":"Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury","volume":"115","author":"Mori","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.09.005_bib29","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1097\/01.ASN.0000145013.44578.45","article-title":"Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin","volume":"15","author":"Mishra","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.ki.5002165","article-title":"Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage","volume":"71","author":"Mori","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/BJ20051020","article-title":"Neutrophil gelatinase-associated lipocalin as a survival factor","volume":"391","author":"Tong","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.kint.2016.09.005_bib32","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ki.2008.395","article-title":"Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in\u00a0vitro and in\u00a0vivo","volume":"74","author":"Wei","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1074\/jbc.M111.308296","article-title":"Lipocalin-2 (24p3\/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis","volume":"287","author":"Langelueddecke","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.09.005_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A\u00a0cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.kint.2016.09.005_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"Schmidt-Ott","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib36","first-page":"463","article-title":"Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle","volume":"5","author":"Devarajan","year":"2007","journal-title":"Cancer Ther"},{"key":"10.1016\/j.kint.2016.09.005_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.09.005_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1755.2000.00205.x","article-title":"Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation","volume":"58","author":"Okada","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4161\/cc.7.9.5804","article-title":"Hypoxia-inducible factor signaling in the development of tissue fibrosis","volume":"7","author":"Higgins","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.kint.2016.09.005_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1\u03b1 causes renal cyst expansion through calcium-activated chloride secretion","volume":"25","author":"Buchholz","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","article-title":"Involvement of hypoxia-inducible transcription factors in polycystic kidney disease","volume":"170","author":"Bernhardt","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.09.005_bib43","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (mTOR) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.09.005_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib47","doi-asserted-by":"crossref","first-page":"e33626","DOI":"10.1371\/journal.pone.0033626","article-title":"Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2016.09.005_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib50","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2010.457","article-title":"mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression","volume":"79","author":"Huber","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib51","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","author":"Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4773(99)00074-X","article-title":"Kidney-specific cadherin (cdh16) is expressed in embryonic kidney, lung, and sex ducts","volume":"84","author":"Wertz","year":"1999","journal-title":"Mech Dev"},{"key":"10.1016\/j.kint.2016.09.005_bib53","first-page":"F146","article-title":"Immunolocalization of Ksp-cadherin in the\u00a0adult and developing rabbit kidney","volume":"277","author":"Thomson","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2016.09.005_bib54","first-page":"F587","article-title":"Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity","volume":"277","author":"Whyte","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2016.09.005_bib55","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1097\/01.ASN.0000016443.50138.CD","article-title":"A\u00a0minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract","volume":"13","author":"Shao","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib56","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1046\/j.1523-1755.2000.00433.x","article-title":"Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography","volume":"58","author":"Sise","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10157-013-0834-4","article-title":"Kidney volume and function in autosomal dominant polycystic kidney disease","volume":"18","author":"Higashihara","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib60","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2016.09.005_bib61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.1995.62","article-title":"Epidermal growth factor receptor expression is abnormal in murine polycystic kidney","volume":"47","author":"Orellana","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib62","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2016.09.005_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib64","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib65","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.0408518102","article-title":"Caspase inhibition reduces tubular apoptosis\u00a0and proliferation and slows disease progression in polycystic kidney disease","volume":"102","author":"Tao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.09.005_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1681\/ASN.2006121378","article-title":"Caspase-3 gene deletion prolongs survival in polycystic kidney disease","volume":"19","author":"Tao","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib67","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1172\/JCI42004","article-title":"Lipocalin 2 is essential for chronic kidney disease progression in mice and humans","volume":"120","author":"Viau","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.09.005_bib68","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2014.427","article-title":"Glycogen synthase kinase-3\u03b2 promotes cyst expansion in polycystic kidney disease","volume":"87","author":"Tao","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.09.005_bib69","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1681\/ASN.2004070595","article-title":"Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease","volume":"16","author":"Nagao","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2011030277","article-title":"c-Met and NF-\u03baB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease","volume":"23","author":"Qin","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib71","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.09.005_bib72","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nbt822","article-title":"High-throughput\u00a0engineering of the mouse genome coupled with high-resolution expression analysis","volume":"21","author":"Valenzuela","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.kint.2016.09.005_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1015594702522","article-title":"FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study","volume":"19","author":"Mady","year":"2002","journal-title":"Clin Exp Metastasis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816304884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816304884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:59:45Z","timestamp":1612141185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816304884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0085253816304884"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.09.005","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}